Connor, Clark & Lunn Investment Management Ltd. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2023$821,221
-23.0%
12,994
-45.2%
0.00%
-33.3%
Q1 2023$1,067,073
+68.5%
23,718
+64.1%
0.01%
+50.0%
Q4 2022$633,186
+167.2%
14,453
+301.7%
0.00%
+100.0%
Q3 2022$237,000
-77.8%
3,598
-62.2%
0.00%
-66.7%
Q4 2020$1,068,0009,5250.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders